| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |